US SB1813 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 39-22-3)
Status: Introduced on May 25 2021 - 25% progression, died in committee
Action: 2021-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 25 2021 - 25% progression, died in committee
Action: 2021-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes.
Title
Accelerating Access to Critical Therapies for ALS Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-05-25 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3537 (Same As) 2021-12-23 - Became Public Law No: 117-79.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/1813/all-info |
| Text | https://www.congress.gov/117/bills/s1813/BILLS-117s1813is.pdf |
